Affiliation: University of Rome Tor Vergata
- Pharmaceutical price controls and minimum efficacy regulation: evidence from the United States and ItalyVincenzo Atella
University of Rome Tor Vergata, Rome 00133, Italy
Health Serv Res 47:293-308. 2012....
- Who is responsible for your health: is it you, your doctor or the new technologies?Vincenzo Atella
CEIS Tor Vergata, Facoltà di Economia, Universita di Roma Tor Vergata, Via Columbia 2, 00133, Rome, Italy
Eur J Health Econ 16:835-46. 2015..25% in patients in primary prevention. Furthermore, we show that recovering to a good health status is a multifaceted phenomenon, with technology explaining from 54 to 68% of the total effect...
- The effect of age and time to death on primary care costs: the Italian experienceVincenzo Atella
Centre for Economic and International Studies CEIS, University of Tor Vergata, Via Columbia 2, 00133 Rome, Italy Center for Health Policy Center for Primary Care and Outcomes Research, 117 Encina Commons Stanford University Stanford, CA 94305 6019, USA Electronic address
Soc Sci Med 114:10-7. 2014..Therefore, our advice to policy makers is to use disaggregated models to better disentangle these contributions and to produce more reliable health spending forecasts. ..
- The impact of cost-sharing schemes on drug compliance in Italy: evidence based on quantile regressionVincenzo Atella
Department of Economics and Finance, University of Rome Tor Vergata, CHP PCOR Stanford University, via Columbia, 2, 00133, Rome, Italy
Int J Public Health 59:329-39. 2014..In this article we investigate the causal effect of cost-sharing schemes on compliance with statins in a quantile regression framework...
- Drug cost containment policies in Italy: are they really effective in the long-run? The case of minimum reference priceV Atella
SEFEMEQ CEIS Faculty of Economics, University of Roma II Tor Vergata, Via di Tor Vergata snc, 00133, Rome, Italy
Health Policy 50:197-218. 2000..Changes in the up-ward trends can be obtained only with joint intervention on both supply and demand side. At the same time, a cost containment policy that acts on prices can have serious implications in terms of welfare...
- Are primary care physicians, public and private sector specialists substitutes or complements? Evidence from a simultaneous equations model for count dataVincenzo Atella
CEIS SEFEMEQ, University of Rome Tor Vergata, Rome, Italy
J Health Econ 27:770-85. 2008..Once common unobserved heterogeneity is properly accounted for, general practitioners, public and private specialists are found to be substitute sources of medical care. In contrast, a naive model finds they are complements...
- Drug compliance, co-payment and health outcomes: evidence from a panel of Italian patientsVincenzo Atella
Faculty of Economics, University of Rome Tor Vergata, Rome, Italy
Health Econ 15:875-92. 2006..Our results show that drug co-payment has a strong effect on compliance, and that this effect is immediate...
- Affordability of medicines and patients' cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UKVincenzo Atella
Centre of International Studies on Economic Growth CEIS Dipartimento di Studi Economico Finanziari e Metodi Quantitativi SEFEMEQ, Faculty of Economics, University of Rome Tor Vergata, Rome, Italy
Appl Health Econ Health Policy 4:23-35. 2005..Therefore, the aim of this article is to explore empirically how, and to what extent, costs incurred by patients influence their decision-making behaviour in accessing medicines...
- Determinants of access to physician services in Italy: a latent class seemingly unrelated probit approachVincenzo Atella
Department of Economics, CEIS Tor Vergata and SEFEMEQ, University of Rome Tor Vergata, Rome, Italy
Health Econ 13:657-68. 2004..Richer individuals are less likely to seek care from GP's and more likely to seek care from specialists, and especially private specialists. Health status and societal vulnerability are the most important indicators of class membership...
- Are employers discriminating with respect to weight? European Evidence using Quantile RegressionVincenzo Atella
University of Rome Tor Vergata, CEIS Tor Vergata and CHILD, Italy
Econ Hum Biol 6:305-29. 2008....
- Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, iV Atella
Department of Economics, University of Rome Tor Vergata, Rome, Italy
Atheroscler Suppl 10:3-21. 2009..Failure to bridge the gap between science and health policy, particularly in relation to lipid management, could result in missed opportunities to reverse the burgeoning epidemic of CVD in Europe...
- Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparisonKaren Hassell
School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, United Kingdom
Eur J Public Health 13:18-23. 2003..This paper describes how the charge system influences the prescribing decisions of Italian and UK physicians...